22-35746492-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001349999.2(RBFOX2):c.1207G>T(p.Ala403Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000158 in 1,452,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )
Consequence
RBFOX2
NM_001349999.2 missense
NM_001349999.2 missense
Scores
1
9
7
Clinical Significance
Conservation
PhyloP100: 5.67
Genes affected
RBFOX2 (HGNC:9906): (RNA binding fox-1 homolog 2) This gene is one of several human genes similar to the C. elegans gene Fox-1. This gene encodes an RNA binding protein that is thought to be a key regulator of alternative exon splicing in the nervous system and other cell types. The protein binds to a conserved UGCAUG element found downstream of many alternatively spliced exons and promotes inclusion of the alternative exon in mature transcripts. The protein also interacts with the estrogen receptor 1 transcription factor and regulates estrogen receptor 1 transcriptional activity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.38910615).
BS2
High AC in GnomAdExome4 at 23 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBFOX2 | NM_001349999.2 | c.1207G>T | p.Ala403Ser | missense_variant | 12/14 | ENST00000695854.1 | NP_001336928.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBFOX2 | ENST00000695854.1 | c.1207G>T | p.Ala403Ser | missense_variant | 12/14 | NM_001349999.2 | ENSP00000512219.1 | |||
RBFOX2 | ENST00000438146.7 | c.1219G>T | p.Ala407Ser | missense_variant | 12/14 | 1 | ENSP00000413035.2 | |||
RBFOX2 | ENST00000449924.6 | c.1006G>T | p.Ala336Ser | missense_variant | 11/13 | 1 | ENSP00000391670.2 | |||
RBFOX2 | ENST00000414461.6 | c.966G>T | p.Leu322Leu | synonymous_variant | 10/12 | 1 | ENSP00000407855.2 | |||
RBFOX2 | ENST00000695805.1 | n.*500G>T | non_coding_transcript_exon_variant | 11/13 | ENSP00000512185.1 | |||||
RBFOX2 | ENST00000695807.1 | n.*4190G>T | non_coding_transcript_exon_variant | 13/15 | ENSP00000512187.1 | |||||
RBFOX2 | ENST00000695805.1 | n.*500G>T | 3_prime_UTR_variant | 11/13 | ENSP00000512185.1 | |||||
RBFOX2 | ENST00000695807.1 | n.*4190G>T | 3_prime_UTR_variant | 13/15 | ENSP00000512187.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1452418Hom.: 0 Cov.: 30 AF XY: 0.0000194 AC XY: 14AN XY: 722766
GnomAD4 exome
AF:
AC:
23
AN:
1452418
Hom.:
Cov.:
30
AF XY:
AC XY:
14
AN XY:
722766
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 407 of the RBFOX2 protein (p.Ala407Ser). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RBFOX2-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
T
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
P;B;P;B;P
Vest4
MutPred
0.42
.;.;Gain of glycosylation at A313 (P = 0);.;.;
MVP
MPC
1.8
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at